7 results
Evaluation of Lymphadenopathy - Localized vs Generalized #Diagnosis #EM #IM #Honc #Lymphadenopathy #Localized #Generalized #Infectious #Malignancy
Evaluation of Lymphadenopathy ... vs Generalized #Diagnosis ... #EM #IM #Honc # ... Generalized #Infectious #Malignancy ... Differential #Algorithm #Ddxof
Algorithm for the Evaluation of Anemia #Diagnosis #EM #IM #Honc #Anemia #Differential #Workup #Algorithm #Microcytic #Macrocytic
Algorithm for the Evaluation ... of Anemia #Diagnosis ... #EM #IM #Honc # ... Macrocytic #Normocytic #Ddxof
Differential Diagnosis of Hypoglycemia
Evaluation of Hypoglycemia
Patients with known diabetes who are not systemically ill and can
Differential Diagnosis ... of Hypoglycemia Evaluation ... #EM #IM #Hypoglycemia ... Algorithm #Drugs #Malignancy ... #Hypoglycemic #Ddxof
Algorithm for Evaluation of Suspected Pulmonary Embolism #Diagnosis #EM #IM #PCC #PulmonaryEmbolism #Pulmonary #Embolism #DDimer #CTA
Algorithm for Evaluation ... of Suspected Pulmonary ... Embolism #Diagnosis ... #EM #IM #PCC #PulmonaryEmbolism ... CTA #Algorithm #Ddxof
Pulmonary Nodule
Evaluation is guided by nodule size & assessment of probability of malignancy. In addition is
Pulmonary Nodule ... Evaluation is guided ... yield of available diagnostic ... The treatment of ... 70% to 90% for a diagnosis
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
are excellent at evaluating ... with presence of pulmonary ... & Dry) is the treatment ... & Dry” is the treatment ... icu #clinical #pharmacology
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
Disease: • 10%-15% Pulmonary ... , INC risk PE, Pulmonary ... and Arthritis Malignancy ... Adenocarcinoma Treatment ... lubricants • Pharmacologic